Breaking News Instant updates and real-time market news.

SYY

Sysco

$62.92

0.02 (0.03%)

, BK

BNY Mellon

$56.89

-0.42 (-0.73%)

17:42
05/15/18
05/15
17:42
05/15/18
17:42

Trian keeps P&G as top holding, cuts stakes in Mondelez, Wendy's

Nelson Peltz's Trian Fund Management disclosed in an SEC filing its holdings as of March 31, 2018. Trian increased its holdings in Sysco (SYY), Bank of New York Mellon (BK), and General Electric (GE) and decreased its holdings in Mondelez (MDLZ), Wendy's (WEN), and Pentair (PNR). The firm's top holdings as of March 31, 2018, in order of size, were Procter & Gamble (PG), Sysco, GE, BNY Mellon, and Mondelez.

SYY

Sysco

$62.92

0.02 (0.03%)

BK

BNY Mellon

$56.89

-0.42 (-0.73%)

GE

General Electric

$14.71

(0.00%)

MDLZ

Mondelez

$39.41

0.19 (0.48%)

WEN

Wendy's

$16.53

0.26 (1.60%)

PNR

Pentair

$44.99

0.16 (0.36%)

PG

Procter & Gamble

$72.94

-0.35 (-0.48%)

  • 16

    May

  • 16

    May

  • 30

    May

  • 05

    Jun

  • 13

    Jun

SYY Sysco
$62.92

0.02 (0.03%)

04/17/18
FBCO
04/17/18
INITIATION
FBCO
Outperform
Sysco initiated with an Outperform at Credit Suisse
Credit Suisse analyst Judah Frommer initiated Sysco with an Outperform rating and $68 price target, calling the company an "industry-leading bellwether with resources that dwarf competitors," which "should enable continued growth with the most profitable customers."
04/17/18
FBCO
04/17/18
INITIATION
FBCO
Outperform
Sysco initiated with an Outperform at Credit Suisse
02/06/18
LOOP
02/06/18
NO CHANGE
Target $70
LOOP
Buy
Sysco's higher operating expenses reduced profits, says Loop Capital
Loop Capital analyst Andrew Wolf reduced his price target on Sysco to $70 from $72 citing greater than anticipated Q2 operating expenses as well as to reflect the recent market correction in the stock. Longer term, the analyst keeps his Buy rating, forecasting the expense pressures to moderate and combined sales productivity to produce an acceleration of operating profit growth.
01/31/18
LOOP
01/31/18
NO CHANGE
Target $72
LOOP
Buy
Sysco price target raised to $72 from $68 at Loop Capital
Loop Capital analyst Andrew Wolf raised his price target on Sysco to $72 ahead of Q2 earnings, saying continued solid fundamentals and the anticipated benefits of tax reform should preserve the positive investor sentiment. The analyst keeps his Buy rating on Sysco, attributing the price target increase to the lower modeled effective tax rate.
BK BNY Mellon
$56.89

-0.42 (-0.73%)

01/19/18
01/19/18
UPGRADE
Target $64

Overweight
Morgan Stanley upgrades BNY Mellon, says reaction to investments overblown
As previously reported, Morgan Stanley analyst Betsy Graseck upgraded BNY Mellon to Overweight from Equal Weight, contending that the negative reaction in the stock following management's report of plans to reinvest the "vast majority" of tax savings is overblown. However, Graseck previously highlighted that new CEO Charlie Scharf could slow the pace of operating leverage and lower taxes provide an excellent opportunity to reinvest in the business without sacrificing EPS growth, she tells investors. Given that trust banks are at the nexus of "the next big wave of Fin-Tech disruption," namely corporate payments, Graseck believes tech investments should drive share gains for BNY Mellon, she added. The analyst raised her price target on BNY Mellon shares to $64 from $60.
03/07/18
BOFA
03/07/18
UPGRADE
BOFA
Neutral
BNY Mellon upgraded to Neutral from Underperform at BofA/Merrill
03/07/18
03/07/18
UPGRADE
Target $58

Neutral
BNY Mellon upgraded to Neutral on balanced risk/reward at BofA/Merrill
As previously reported, BofA/Merrill upgraded BNY Mellon to Neutral from Underperform and raised tis price target to $58 from $54. Analyst Michael Carrier expects this week's investor Day to be a positive event, highlighting growth initiatives, cost efficiencies and capital management. Carrier views risk/reward as more balanced saying business trends are decent, but some headwinds remain.
03/12/18
GSCO
03/12/18
DOWNGRADE
Target $60
GSCO
Neutral
BNY Mellon downgraded to Neutral on valuation at Goldman Sachs
Goldman analyst Alexander Blostein downgraded BNY Mellon to Neutral from Buy citing valuation reflects near-term earnings growth and maintained a $60 price target.
GE General Electric
$14.71

(0.00%)

05/04/18
JPMS
05/04/18
NO CHANGE
Target $11
JPMS
Underweight
GE really sold Industrial Solutions for $1.9B, not $2.6B, says JPMorgan
JPMorgan analyst Stephen Tusa says new disclosures in General Electric's quarterly filing show that the net proceeds from the Industrial Solutions sale will be $1.9B, not the headline $2.6B. This is partly because of taxes but also because of the company's disclose that "cash to be received by GE Capital for receivables originated in our Industrial Solutions business and sold to them," Tusa tells investors in a research note titled "GE Industrial Solutions: A Window Into Asset Sales and How $2.6 B Becomes $1.9 B, and Arguably Close to Zero." Further, he notes that the majority of pension liabilities are staying with GE. This is "another bite out of the proceeds," Tusa writes. He believes assets sales such as this are "unattractive for the shareholder, and should be viewed as such by ratings agencies, which remain seemingly and surprisingly patient and accommodating." The analyst keeps an Underweight rating on General Electric with an $11 price target.
05/10/18
JPMS
05/10/18
NO CHANGE
Target $11
JPMS
Underweight
Spread between GE's adjusted, GAAP results widest on record, says JPMorgan
The difference between General Electric's "adjusted" earnings per share, which is being used by consensus and retail investors to value the stock today, and GAAP is the "widest we have on record," JPMorgan analyst Stephen Tusa tells investors in a research note. The difference is around 50%, higher than ever seen during prior CEO Jeff Immelt's tenure, with "still worst-in-class" consensus free cash flow conversion, Tusa writes in a note titled "Quality vs. Quantity: When Will GEs EPS Recouple and Align with Peers? And Other Notable Items." The analyst keeps an Underweight rating on General Electric with an $11 price target.
05/14/18
05/14/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. General Electric (GE) initiated with a Buy at Gabelli. 2. Western Digital (WDC) initiated with an Overweight at JPMorgan. 3. GrafTech (EAF) initiated with an Overweight at JPMorgan and an Outperform at RBC Capital. 4. Surface Oncology (SURF) initiated with an Outperform at Evercore ISI and Cowen as well as a Neutral at Goldman Sachs. 5. BeiGene (BGNE) initiated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/14/18
GABE
05/14/18
INITIATION
GABE
Buy
General Electric initiated with a Buy at Gabelli
Gabelli analyst Justin Bergner initiated coverage on General Electric with a Buy and $22.50 price target. Bergner believes General Electric has the right leadership in place, with high quality assets in Aviation and Healthcare, that provide a margin of safety, and a path to de-leverage which does not require a fire sale of assets.
MDLZ Mondelez
$39.41

0.19 (0.48%)

02/02/18
02/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MasterCard (MA) upgraded to Buy from Hold at Argus with analyst Stephen Biggar saying the stock should trade above its historical average earnings multiple, with effective tax rate of 20% seen below 27% in 2017 as well as continued strong purchase volumes and growth in cross-border volumes and processed transactions. 2. Tableau (DATA) upgraded to Hold from Sell at Maxim with analyst Nehal Chokshi citing normalized bookings accelerating to 26% growth in the fourth quarter and sees normalized sales productivity stabilizing at about a 33% level. 3. Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale with analyst Warren Ackerman saying fourth quarter results were "solid" as emerging markets are rebounding strongly and the worst is over in North America. 4. Huntington Ingalls (HII) upgraded to Outperform from Market Perform at Cowen with analyst Gautam Khanna saying the shares are "excessively discounted" relative to the large cap defense peer average. 5. Sherwin-Williams (SHW) upgraded to Buy from Neutral at Seaport Global with analyst Michael Harrison saying the Valspar deal adds another layer of potential growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/10/18
UBSW
04/10/18
DOWNGRADE
Target $90
UBSW
Sell
UBS downgrades Hershey to Sell on reduced chocolate buying frequency
UBS analyst Steven Strycula downgraded Hershey (HSY) to Sell from Neutral and cut his price target for the shares to $90 from $106. The stock closed yesterday up 51c to $99.36. Hershey's portfolio is over-exposed to slowing category consumption, intensifying competition, and rising cocoa prices, Strycula tells investors in a research note. The analyst notes that his firm's research indicates reduced purchase frequency for everyday chocolate as preferences shift consumption to healthier snack alternatives and online purchases. These "longer-tailed trends" carry negative margin mix and potential distribution losses for Hershey, he writes. Further, Strycula sees risk of Hershey losing U.S. share as Mars ramps production capacity, Ferrero revitalizes Nestle's legacy U.S. portfolio and Mondelez (MDLZ) accelerates its entry into U.S. chocolate.
05/15/18
BOFA
05/15/18
NO CHANGE
BOFA
Mondelez, Fluor added to US 1 List at BofA/Merrill
04/16/18
FBCO
04/16/18
NO CHANGE
Target $48
FBCO
Outperform
Mondelez price target lowered to $48 from $53 at Credit Suisse
Credit Suisse analyst Robert Moskow lowered his price target for Mondelez to $48 from $53 on valuation. The analyst reiterates an Outperform rating on the shares.
WEN Wendy's
$16.53

0.26 (1.60%)

05/15/18
STFL
05/15/18
NO CHANGE
Target $20
STFL
Buy
Wendy's pullback creates buying opportunity, says Stifel
Stifel analyst Chris O'Cull said he views the pullback in Wendy's shares following its Q1 earnings as a buying opportunity because severe winter weather impacting company-owned restaurants was the reason for the miss compared to expectations and nothing from the report changed his investment thesis. He maintains a Buy rating and $20 price target on Wendy's shares.
03/20/18
03/20/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wendy's (WEN) initiated with a Perform at Oppenheimer. 2. Adesto Technologies (IOTS) initiated with a Buy at B. Riley FBR. 3. M.D.C. Holdings (MDC) initiated with a Neutral at Wedbush. 4. Marinus Pharmaceuticals (MRNS) initiated with a Buy at Mizuho. 5. J.B. Hunt (JBHT) initiated with a Buy at Argus. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/19/18
OPCO
03/19/18
INITIATION
OPCO
Perform
Wendy's initiated with a Perform at Oppenheimer
Oppenheimer analyst Brian Bittner initiated Wendy's with a Perform rating, saying the company's investment story is focused around the management's 75% growth target for free cash flows based on accelerating sales, lower capital expenses, and positive tax changes. The analyst notes that while the company is "executing solidly", his Perform rating is based on financial targets already "baked in" to valuation and some "meaningful dependence" of free cash flow projections on strong comps and unit offerings. Bittner add that he is "positively biased" on any "irrational pullbacks" in the stock price.
03/15/18
MZHO
03/15/18
INITIATION
Target $19
MZHO
Buy
Wendy's initiated with a Buy at Mizuho
Mizuho analyst Jeremy Scott initiated Wendy's with a Buy and $19 price target.
PNR Pentair
$44.99

0.16 (0.36%)

05/03/18
RBCM
05/03/18
DOWNGRADE
Target $49
RBCM
Sector Perform
Pentair downgraded to Sector Perform at RBC Capital on completion of breakup
As reported earlier, RBC Capital analyst Deane Dray downgraded Pentair and lowered his price target to $49 from $79. The analyst notes the completion of the "breakup catalyst" following the company's spin-off of the electrical business, saying that despite the management's initiatives, valuation on the stock is at "fair value".
05/15/18
COWN
05/15/18
UPGRADE
Target $52
COWN
Outperform
Pentair upgraded two notches to Outperform at Cowen
As previously reported, Cowen analyst Joseph Giordano upgraded Pentair to Outperform from Underperform, as he believes the company "finally" has a true identity as a pure play water equipment and technology provider. The analyst met with management, who gave a balanced approach with better comp alignment and reasonable targets that can be exceeded. He also said his proprietary pool survey implied a meaningful runway for the company's strongest business. Giordano raised his price target to $52 from $43.50 on Pentair shares.
05/15/18
COWN
05/15/18
UPGRADE
COWN
Outperform
Pentair upgraded to Outperform from Underperform at Cowen
05/14/18
LEHM
05/14/18
NO CHANGE
Target $40
LEHM
Underweight
Pentair price target cut to $40 from $66 at Barclays
Barclays analyst Julian Mitchell lowered his price target on Pentair (PNR) to $40 from $66 following the spinoff of the company's Electrical business nVent Electric (NVT). In a research note to investors, Mitchell contended that Pentair has grown margins at a solid clip over the last few years despite "lackluster" performance on the top-line, adding that the current valuation suggests investors are already pricing in guidance raises and that any earnings missteps are likely to be accompanied by "considerable" valuation multiple compression.
PG Procter & Gamble
$72.94

-0.35 (-0.48%)

04/20/18
RHCO
04/20/18
NO CHANGE
Target $75
RHCO
Hold
Procter & Gamble price target lowered to $75 from $90 at SunTrust
SunTrust analyst William Chappell lowered his price target on Procter & Gamble to $75 after the company's in-line Q3 earnings and updated guidance. Chappell says the continued success of Laundry, Beauty, and Health Care segments are encouraging, but also sees "little visibility" on when he can expect Baby and Grooming segments' pricing environment to improve. The analyst keeps his Hold rating on Procter & Gamble amid ongoing issues in the Baby, Feminine & Family Care segment, with Q1 growth down 3% driven by 2% decline in volume and 1% decline in price.
04/20/18
04/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Neutral from Buy at BofA/Merrill and to Hold from Buy at Deutsche Bank aw well as Argus. 2. Philip Morris (PM) downgraded to Buy from Conviction Buy at Goldman Sachs and to Underperform from Neutral at BofA/Merrill. 3. DHT Holdings (DHT) downgraded to Neutral from Overweight at JPMorgan with analyst Noah Parquette saying he has become more constructive on a crude tanker recovery in 2019 but cites relative valuation for the downgrade on DHT. 4. Skechers (SKX) downgraded to Neutral from Outperform at Wedbush with analyst Christopher Svezia citing the company's first quarter results. 5. Tyson Foods (TSN) downgraded to Hold from Buy at Vertical Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/20/18
ARGS
04/20/18
DOWNGRADE
ARGS
Hold
Procter & Gamble downgraded to Hold at Argus on limited organic growth recovery
As reported earlier, Argus analyst John Staszak downgraded Procter & Gamble to Hold from Buy, saying organic growth has not improved to the expected extent even after the company spun off its Beauty and other businesses in recent years. Staszak adds P&G continues to lose market share to "fierce" competition, while its margin expansion has also slowed. The analyst sees the current valuation multiple of 17.7-times his FY18 EPS view as fair, but adds he would consider a more constructive stance if organic growth accelerated.
04/20/18
ARGS
04/20/18
DOWNGRADE
ARGS
Hold
Procter & Gamble downgraded to Hold from Buy at Argus

TODAY'S FREE FLY STORIES

13:10
11/19/18
11/19
13:10
11/19/18
13:10
General news
Euro$ interest rate futures are feeling their oats »

Euro$ interest rate…

BSX

Boston Scientific

$35.50

-1.72 (-4.62%)

13:05
11/19/18
11/19
13:05
11/19/18
13:05
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AA

Alcoa

$33.20

-2.73 (-7.60%)

13:05
11/19/18
11/19
13:05
11/19/18
13:05
Options
Alcoa call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$131.85

-7.7 (-5.52%)

13:04
11/19/18
11/19
13:04
11/19/18
13:04
Periodicals
Instagram is removing inauthentic followers, TechCrunch reports »

Facebook's Instagram…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LRLCY

L'Oreal

$0.00

(0.00%)

13:03
11/19/18
11/19
13:03
11/19/18
13:03
Hot Stocks
L'Oreal appoints Christophe Babule to succeed Christian Mulliez as CFO »

L'Oreal announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$37.48

2.52 (7.21%)

13:03
11/19/18
11/19
13:03
11/19/18
13:03
Hot Stocks
Tesaro rallies after canceling appearance at Evercore conference »

Shares of Tesaro are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

SCGLY

Societe Generale

$0.00

(0.00%)

12:56
11/19/18
11/19
12:56
11/19/18
12:56
Hot Stocks
Societe Generale says $1.3B settlement covered by provision for disputes »

Societe Generale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$13.47

-1.01 (-6.98%)

12:55
11/19/18
11/19
12:55
11/19/18
12:55
Options
Bilibili put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

12:55
11/19/18
11/19
12:55
11/19/18
12:55
General news
Treasury Action: yields rolled over from highs »

Treasury Action: yields…

TWTR

Twitter

$32.25

-1.45 (-4.30%)

12:49
11/19/18
11/19
12:49
11/19/18
12:49
Periodicals
Twitter de-emphasize follower counts in iOS redesign, Verge says »

The follower count on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

PBR

Petrobras

$14.60

-0.27 (-1.82%)

12:46
11/19/18
11/19
12:46
11/19/18
12:46
Periodicals
Petrobras' Branco says BR Distribuidora not a natural fit, Reuters says »

Incoming Petrobras CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$114.20

0.35 (0.31%)

12:45
11/19/18
11/19
12:45
11/19/18
12:45
Options
Eli Lilly call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

INGN

Inogen

$137.12

-4.73 (-3.33%)

, RMD

ResMed

$102.53

-1.58 (-1.52%)

12:43
11/19/18
11/19
12:43
11/19/18
12:43
Recommendations
Inogen, ResMed analyst commentary  »

Mobi looks…

INGN

Inogen

$137.12

-4.73 (-3.33%)

RMD

ResMed

$102.53

-1.58 (-1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 04

    Dec

MDT

Medtronic

$90.66

-3.02 (-3.22%)

12:35
11/19/18
11/19
12:35
11/19/18
12:35
Options
Medtronic put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

SCGLY

Societe Generale

$0.00

(0.00%)

12:34
11/19/18
11/19
12:34
11/19/18
12:34
Hot Stocks
Societe Generale agrees to pay $1.34B for violations of U.S. sanctions »

The Federal Reserve Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

12:30
11/19/18
11/19
12:30
11/19/18
12:30
Periodicals
China's WTO envoy says China to propose WTO changes, Reuters says »

Zhang Xiangchen,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$30.41

0.11 (0.36%)

12:26
11/19/18
11/19
12:26
11/19/18
12:26
Periodicals
White House still seeking to take Jim Acosta's press pass away, WSJ says »

The White House is still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

PEP

PepsiCo

$118.30

-0.09 (-0.08%)

12:25
11/19/18
11/19
12:25
11/19/18
12:25
Options
PepsiCo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

AAL

American Airlines

$35.36

-1.38 (-3.76%)

12:22
11/19/18
11/19
12:22
11/19/18
12:22
Hot Stocks
APA seeks to open contract negotiations with American Airlines »

The Allied Pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMX

Aevi Genomics Medicine

$1.12

-0.04 (-3.45%)

12:16
11/19/18
11/19
12:16
11/19/18
12:16
Conference/Events
Aevi Genomics Medicine management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/19/18
11/19
12:16
11/19/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$21.82

-0.43 (-1.93%)

12:15
11/19/18
11/19
12:15
11/19/18
12:15
Options
Teva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

PRT

PermRock Royalty Trust

$10.75

-1.3 (-10.79%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
PermRock Royalty Trust falls -10.9% »

PermRock Royalty Trust is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$23.54

-4.46 (-15.93%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Colfax falls -15.9% »

Colfax is down -15.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.